A5082462527- Transplantation: Methods and Outcomes
- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Renal Transplantation Outcomes and Treatments
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Hepatitis C virus research
- Congenital Heart Disease Studies
- Inflammatory Biomarkers in Disease Prognosis
- Cardiac Arrest and Resuscitation
- Cardiac pacing and defibrillation studies
- Adipokines, Inflammation, and Metabolic Diseases
- Organ Transplantation Techniques and Outcomes
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiac Valve Diseases and Treatments
- Cardiovascular Health and Disease Prevention
- Cardiovascular Disease and Adiposity
- Viral Infections and Immunology Research
- Lipoproteins and Cardiovascular Health
- Hemodynamic Monitoring and Therapy
- Cardiovascular Health and Risk Factors
- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
- Chronic Kidney Disease and Diabetes
Vanderbilt University Medical Center
2016-2025
Vanderbilt University
2015-2023
University of Mississippi Medical Center
2023
Jackson Memorial Hospital
2023
Faculty of 1000 (United States)
2021
RELX Group (United States)
2021
Vanderbilt Health
2018-2020
AdventHealth Orlando
2020
Preston University
2017-2018
Advocate Christ Medical Center
2016
For patients awaiting heart transplant, hepatitis C-positive donors offer an opportunity to expand the donor pool, shorten wait times, and decrease wait-list mortality. While early reported outcomes among few transplant recipients have been promising, knowledge of 1-year in larger cohorts is critical shared decision-making with about this option.To better define association volumes, duration, transmission cure donor-derived C, morbidity mortality at 1 year.This was a prospective,...
Objective This study was designed to examine the utility of two-dimensional strain (2DS) or speckle tracking imaging typify functional adaptations left ventricle in variant forms ventricular hypertrophy (LVH). Design Cross-sectional study. Setting Urban tertiary care academic medical centres. Participants A total 129 subjects, 56 with hypertrophic cardiomyopathy (HCM), 34 hypertensive (H-LVH), 27 professional athletes LVH (AT-LVH) and 12 healthy controls sinus rhythm preserved systolic...
BackgroundThe studied associations between serum uric acid (sUA) and cardiovascular disease (CVD) events have been controversial. We sought to evaluate the association sUA CVD mortality, including its ability reclassify risk in a multiethnic nationally representative population free of clinical diabetes at baseline.
Red cell distribution width (RDW) and hemoglobin A1c (HbA1c) are both known to be predictive of future cardiovascular disease (CVD).We hypothesized that RDW would associated with HbA1c in adults without diabetes independent fasting blood glucose (FBG).This cross-sectional study included 15,343 nondiabetic adults, free CVD, enrolled NHANES 1999-2008. Adjusted means were calculated across categories for the overall population. Multivariable regression analyses performed analyzing association...
Red cell distribution width (RDW) is an independent predictor of the 10-year estimated risk coronary heart disease (CHD) events. However, RDW's association with peripheral artery (PAD) - a CHD equivalent has not been evaluated to date. In this cross-sectional study, we examined 6950 participants National Health and Nutrition Examination Survey, 1999-2004. PAD was defined as ankle-brachial index below 0.9 (n = 618). RDW divided into quartiles (Q) (Q1: ≤ 12.2; Q2: 12.3-12.5; Q3: 12.6-13.0; Q4:...
Treatment of adult congenital heart disease patients who require advanced therapies remains challenging due to high perioperative and wait-list mortality limited donors. Patients palliated with Fontan are at the highest risk early multiorgan involvement few centers able safely transplant them. We sought evaluate outcomes transplants in these patients.Using Nationwide Inpatient Sample database, we identified all adults aged least 18 years old underwent transplantation across U.S. hospitals...
The use of a Left Ventricular Assist Device (LVAD) in patients with advanced heart failure refractory to optimal medical management has progressed steadily over the past two decades. Data have demonstrated reduced LVAD efficacy, worse clinical outcome, and higher mortality for who experience significant ventricular tachyarrhythmia (VTA). We hypothesize that novel prophylactic intra-operative VTA ablation protocol at time implantation may reduce recurrent adverse events postimplant.We...